BioCentury
ARTICLE | Clinical News

Fluarix Quadrivalent regulatory update

December 24, 2012 8:00 AM UTC

FDA approved GlaxoSmithKline's seasonal flu vaccine Fluarix Quadrivalent to prevent influenza subtypes A and type B infection in people >=3 years. According to GSK, the vaccine helps protect against t...